共 234 条
[1]
Erqou S(2010)Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants J Am Coll Cardiol 55 2160-2167
[2]
Thompson A(2009)Genetically elevated lipoprotein(a) and increased risk of myocardial infarction JAMA 301 2331-2339
[3]
Di Angelantonio E(1996)Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease Arterioscler Thromb Vasc Biol 16 713-719
[4]
Saleheen D(1990)Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia N Engl J Med 322 1494-1499
[5]
Kaptoge S(2010)Lipoprotein(a) and risk of type 2 diabetes Clin Chem 56 1252-1260
[6]
Marcovina S(2013)Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study Lancet Diabetes Endocrinol 1 220-227
[7]
Danesh J(2013)Abdominal obesity with hypertriglyceridaemia, lipoprotein(a) and apolipoprotein A-I determine marked cardiometabolic risk Eur J Clin Invest 43 1129-1139
[8]
Kamstrup PR(2015)Low, “quotient” Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk Exp Clin Endocrinol Diabetes 123 11-18
[9]
Tybjaerg-Hansen A(2014)The association between circulating lipoprotein(a) and type 2 diabetes: is it causal? Diabetes 63 332-342
[10]
Steffensen R(2015)Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study Lancet 386 1472-1483